The Research and Development team at Secretome Therapeutics is responsible for advancing innovative secretome-based therapies targeting inflammation and mitochondrial dysfunction. This expert group, led by the VP of R&D and supported by multiple directors and scientific advisory board members, conducts cutting-edge research, oversees product development, and collaborates on clinical trials to ensure the efficacy and safety of emerging treatments in the company’s pipeline.
View all